研究成果 (81)

排序依據：日期 | 題名

10 | 25 | 50 | 100

1/4

3 A B C D E F G H I L M N O P Q R S T 全部

30 Immunotherapy in advanced NSCLC - from the 'tsunami' of therapeutic knowledge to a clinical practice algorithm: results from an international expert panel meeting of the Italian Association of Thoracic Oncology (AIOT)
de Marinis F, Ciardiello F, Baas P, Crinò L, Giaccone G, Grossi F, Hellmann MD, Mok TSK, Lena H, Paz-Ares L, Rodriguez-Abreu D, Von Pavel J, Gridelli C ( 2018 )
ESMO Open
Publication in refereed journal
典藏於此文庫的全文:
file.pdf
數位物件識別號 (DOI): http://dx.doi.org/10.1136/esmoopen-2017-000298
Ablative Chemoembolization for Hepatocellular Carcinoma: A Prospective Phase I Case-Control Comparison with Conventional Chemoembolization
Simon Chun Ho Yu, Stephen Lam Chan, Kit Fai Lee, Joyce Wai Yi Hui, Edwin Pun Hui, Cheuk Man Chu, Anthony Wing-hung Chan, Sunny Cheung, Leung Li, John Wong, Winnie Ming Ming Yeo ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1148/radiol.2017170154
Adherence to the World Cancer Research Fund/American Institute for Cancer Research Guideline Is Associated With Better Health-Related Quality of Life Among Chinese Patients With Breast Cancer
Lei YY, Ho SC, Cheng A, Kwok C, Lee CI, Cheung KL, Lee R, Loong HHF, He YQ, Yeo W ( 2018 )
Journal of the National Comprehensive Cancer Network
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.6004/jnccn.2017.7202
Adjusted Indirect Comparison Using Propensity Score Matching of Osimertinib to Platinum-Based Doublet Chemotherapy in Patients with EGFRm T790M NSCLC Who Have Progressed after EGFR-TKI
Mann H, Andersohn F, Bodnar C, Mitsudomi T, Mok TSK, Yang JC, Hoyle C ( 2018 )
Clinical Drug Investigation
Publication in refereed journal
典藏於此文庫的全文:
file.pdf
數位物件識別號 (DOI): http://dx.doi.org/10.1007/s40261-017-0611-3
A feasibility study on using tablet personal computers for self‐reported symptom assessment in newly diagnosed lung cancer patients
Fiona W.K. Tang, Carmen W.H. Chan, Yin‐Ping Choy, Herbert H.F. Loong, Ka Ming Chow, Winnie K.W. So ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1111/ijn.12658
Aflibercept plus FOLFIRI in Asian patients with pretreated metastatic colorectal cancer: a randomized Phase III study
Li J, Xu RH, Qin SK, Liu TS, Pan HM, Xu JM, Bi F, Lim R, Zhang SZ, Ba Y, Bai YX, Fan NF, Tsuji A, Yeh KH, Ma B, Wei V, Shi DM, Magherini E, Shen L, Shen L ( 2018 )
Future Oncology
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.2217/fon-2017-0669
Albumin-bilirubin grade predicts the outcomes of liver resection versus radiofrequency ablation for very early/early stage of hepatocellular carcinoma
Charing Ching-Ning Chong, Anthony Wing-Hung Chan, John Wong, Cheuk-Man Chu, Stephen Lam Chan, Kit-Fai Lee, Simon Chun-Ho Yu, Ka-Fai To, Philip Johnson, Paul Bo-San Lai ( 2018 )
Surgeon
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1016/j.surge.2017.07.003
Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial
Chan ATC, Hui EP, Ngan RKC, Tung SY, Cheng ACK, Ng WT, Lee VHF, Ma BBY, Cheng HC, Wong FCS, Loong HHF, Tong M, Poon DMC, Ahuja AT, King AD, Wang K, Mo F, Zee BCY, Chan KCA, Lo YMD ( 2018 )
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1200/JCO.2018.77.7847
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
Brigette B.Y. Ma, Wan-Teck Lim, Boon-Cher Goh, Edwin P. Hui, Kwok-Wai Lo, Adam Pettinger, Nathan R. Foster, Jonathan W. Riess, Mark Agulnik, Alex Y.C. Chang, Akhil Chopra, Julie A. Kish, Christine H. Chung, Douglas R. Adkins, Kevin J. Cullen, Barbara J. Gitlitz, Dean W. Lim, Ka-Fai To, K.C. Allen Chan, Y.M. Dennis Lo, Ann D. King, Charles Erlichman, Jun Yin, Brian A. Costello, Anthony T.C. Chan ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1200/JCO.2017.77.0388
A randomized, multicenter phase 3 study of durvalumab (D) and tremelimumab (T) as first-line treatment in patients with unresectable hepatocellular carcinoma (HCC): HIMALAYA study
Abou-Alfa GK, Chan SL, Furuse J, Galle PR, Kelley RK, Qin SK ( 2018 )
JOURNAL OF CLINICAL ONCOLOGY
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.TPS4144
Assessment of programmed cell death ligand-1 expression by 4 diagnostic assays and its clinicopathological correlation in a large cohort of surgical resected non-small cell lung carcinoma
Chan AWH, Tong JHM, Kwan JSH, Chow C, Chung LY, Chau SL, Lung RWM, Ng CSH, Wan IYP, Mok TSK, To KF ( 2018 )
Modern Pathology
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1038/s41379-018-0053-3
Association Between Serum Folate Level and Toxicity of Capecitabine During Treatment for Colorectal Cancer
Chan SL, Chan AWH, Mo F, Ma BBY, Wong KCW, Lam D, Mok FST, Chan ATC, Mok T, Chan KCA ( 2018 )
The oncologist
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1634/theoncologist.2017-0637
Association of serum folate level with toxicity of capecitabine in patients with colorectal cancers: a prospective cohort study.
Chan SL, Ma BB, Chan AK ( 2018 )
Hong Kong medical journal = Xianggang yi xue za zhi
Publication in refereed journal
A statistical model for survival risk prediction in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment
Berhane S, Fox R, Chan SL, Yau T, Johnson P ( 2018 )
JOURNAL OF HEPATOLOGY
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1016/S0168-8278(18)30607-X
Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab
David R. Gandara, Sarah M. Paul, Marcin Kowanetz, Erica Schleifman, Wei Zou, Yan Li, Achim Rittmeyer, Louis Fehrenbacher, Geoff Otto, Christine Malboeuf, Daniel S. Lieber, Doron Lipson, Jacob Silterra, Lukas Amler, Todd Riehl, Craig A. Cummings, Priti S. Hegde, Alan Sandler, Marcus Ballinger, David Fabrizio, Tony Mok, David S. Shames ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1038/s41591-018-0134-3
Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: Results from the randomized phase III CELESTIAL trial
Abou-Alfa GK, Meyer T, Cheng AL, El-Khoueiry AB, Rimassa L, Ryoo BY, Cicin I, Merle P, Park JW, Blanc JF, Bolondi L, Klumpen HJ, Chan SL, Dadduzio V, Hessel C, Borgman-Hagey AE, Schwab G, Kelley RK ( 2018 )
JOURNAL OF CLINICAL ONCOLOGY
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1200/JCO.2018.36.4_suppl.207
Clinical Application of Genomic Profiling With Circulating Tumor DNA for Management of Advanced Non-Small-cell Lung Cancer in Asia
Loong HH, Raymond VM, Shiotsu Y, Chua DTT, Teo PML, Yung T, Skrzypczak S, Lanman RB, Mok TSK ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1016/j.cllc.2018.04.022
CNS Efficacy of Osimertinib in Patients With T790M-Positive Advanced Non-Small-Cell Lung Cancer: Data From a Randomized Phase III Trial (AURA3)
Wu YL, Ahn MJ, Garassino MC, Han JY, Katakami N, Kim HR, Hodge R, Kaur P, Brown AP, Ghiorghiu D, Papadimitrakopoulou VA, Mok TSK ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1200/JCO.2018.77.9363
Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-Small Cell Lung Cancer Associated With Poor Prognosis
Niki Karachaliou, Imane Chaib, Andres Felipe Cardona, Jordi Berenguer, Jillian Wilhelmina Paulina Bracht, Jie Yang, Xueting Cai, Zhigang Wang, Chunping Hu, Ana Drozdowskyj, Carles Codony Servat, Jordi Codony Servat, Masaoki Ito, Ilaria Attili, Erika Aldeguer, Ana Gimenez Capitan, July Rodriguez, Leonardo Rojas, Santiago Viteri, Miguel Angel Molina-Vila, Sai-Hong Ignatius Ou, Morihito Okada, Tony S. Mok, TreverG.Bivona, Mayumi Ono, Jean Cui, Santiago Ramón y Cajal, Alex Frias, Peng Cao, Rafael Rosel ( 2018 )
Publication in refereed journal
典藏於此文庫的全文:
publication.pdf
數位物件識別號 (DOI): http://dx.doi.org/10.1016/j.ebiom.2018.02.001
Comparison of Immune Microenvironment in CD8-Rich and CD8-Poor Hepatocellular Carcinoma
Chan A, Chow C, Chan SL, Tong JH, To KF ( 2018 )
Laboratory Investigation
Publication in refereed journal
Comutations in DNA Damage Response Pathways Serve as Potential Biomarkers for Immune Checkpoint Blockade
Wang Z, Zhao J, Wang G, Zhang F, Zhang Z, Zhang F, Zhang Y, Dong H, Zhao X, Duan J, Bai H, Tian Y, Wan R, Han M, Cao Y, Xiong L, Liu L, Wang S, Cai S, Mok TSK, Wang J ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1158/0008-5472.CAN-18-1814
Controversies and consensus of neoadjuvant chemotherapy in soft-tissue sarcomas
Loong HH, Wong KH, Tse T ( 2018 )
ESMO OPEN
Publication in refereed journal
典藏於此文庫的全文:
output.pdf
數位物件識別號 (DOI): http://dx.doi.org/10.1136/esmoopen-2017-000293
Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group
Arvold ND, Armstrong TS, Warren KE, Chang SM, DeAngelis LM, Blakeley J, Chamberlain MC, Dunbar E, Loong HH, Macdonald DR, Reardon DA, Vogelbaum MA, Yuan Y, Weller M, van den Bent M, Wen PY ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1093/neuonc/noy056
Cost-Effectiveness of Screening for Nasopharyngeal Carcinoma with Plasma Epstein-Barr Virus DNA
Harris JP, Saraswathula A, Kaplun BD, Qian Y, Chan KCA, Chan ATC, Le QT, Owens D, Goldhaber-Fiebert JD, Pollom E ( 2018 )
International Journal of Radiation Oncology Biology Physics
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1016/j.ijrobp.2018.07.1184
Dietary changes in the first 3 years after breast cancer diagnosis: a prospective Chinese breast cancer cohort study
Lei YY, Ho SC, Cheng A, Kwok C, Cheung KL, He YQ, Lee CI, Lee R, Yeo W ( 2018 )
Publication in refereed journal
典藏於此文庫的全文:
dietary-changes.pdf
數位物件識別號 (DOI): http://dx.doi.org/10.2147/CMAR.S168562

10 | 25 | 50 | 100

1/4

研究成果 (81)

分享連結

Our policy towards the use of cookies